Trials / Terminated
TerminatedNCT00848107
Open-Label Study of Oral Treprostinil in Digital Ulcers
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- United Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This open label extension trial will allow ongoing treatment of subjects who participated in the randomized controlled trials, and will provide long term information about the safety of treprostinil diethanolamine SR in subjects with SSc and digital ulcers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | treprostinil diethanolamine | sustained release tablet; BID dosing; up to 16 mg BID |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2009-02-20
- Last updated
- 2024-06-18
- Results posted
- 2014-02-07
Locations
26 sites across 3 countries: United States, Canada, United Kingdom
Source: ClinicalTrials.gov record NCT00848107. Inclusion in this directory is not an endorsement.